Gene Green: “Robust competition will ultimately realize the most sustainable, significant savings for the program and the best for…”

Eight years ago, Congress passed the Affordable Care Act to address the HHS Office of Inspector General reports of drug manufacturers overcharging 340B drugs.

The promise of the 21st Century Cures Act is to advance the discovery and development of new treatments and cures through increased research and an improved drug approval process.

I would like to submit the following letters for the record.

I am extremely disappointed that 2 years after the passage of Cures we still do not have the regulations necessary to implement these provisions.